Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yuanzhuang Zhang, Yeqiu Xu, Yuxin Bao, Yinzhou Luo, Guanzhen Qiu, Ming He, Jie Lu, Jian Xu, Bin Chen & Yong Wang. (2023) N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs – an updated review. Epigenetics 18:1.
Read now
Read now
Articles from other publishers (5)
Yishu Fan, Xinyi Lv, Zhuohui Chen, Yanyi Peng & Mengqi Zhang. (2023) m6A methylation: Critical roles in aging and neurological diseases. Frontiers in Molecular Neuroscience 16.
Crossref
Crossref
Belinda J Petri & Carolyn M Klinge. (2023) m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer. Journal of Molecular Endocrinology 70:2.
Crossref
Crossref
Yanan Zhu, Jing Li, Hang Yang, Xinyi Yang, Ya Zhang, Xinchao Yu, Ying Li, Gangxian Chen & Zuozhang Yang. (2023) The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer. Cell Death Discovery 9:1.
Crossref
Crossref
Wenjun Ren, Yixiao Yuan, Yongwu Li, Luciano Mutti, Jun Peng & Xiulin Jiang. (2023) The function and clinical implication of YTHDF1 in the human system development and cancer. Biomarker Research 11:1.
Crossref
Crossref
Zhangci Su, Leyao Xu, Xinning Dai, Mengyao Zhu, Xiaodan Chen, Yuanyuan Li, Jie Li, Ruihan Ge, Bin Cheng & Yun Wang. (2022) Prognostic and clinicopathological value of m6A regulators in human cancers: a meta-analysis. Aging 14:21, pages 8818-8838.
Crossref
Crossref